Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trialLucia Del Mastro, Paolo Bruzzi, Mauro Mansutti et al.|The Lancet Oncology|2021Cited by 86
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studiesMatteo Lambertini, Lucia Del Mastro, Eva Blondeaux et al.|EClinicalMedicine|2023Cited by 28
118O Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: A randomised, phase III trial of the Gruppo Italiano MammellaLucia Del Mastro, Paolo Bruzzi, Mauro Mansutti et al.|Annals of Oncology|2021Cited by 1
Abstract GS3-02: Fertility and ovarian function preservation in premenopausal women with early breast cancer: results from the multicenter prospective PREgnancy and FERtility (PREFER) studyM. Lambertini, Lucia Del Mastro, I. Meattini et al.|Clinical Cancer Research|2026Cited by 0